It is safe to say that the already strong reputation Scott Gottlieb developed during his tenure as Commissioner of the US Food & Drug Administration during the first two years of the Trump Administration has only been burnished by subsequent events.
As a global pandemic has engulfed all other issues, Gottlieb has remained a high-profile voice of public health credibility, while...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?